It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually determined after an approval in the U.S.
Related Posts
Former Treasury Secretary Steven Mnuchin says ‘people are overreacting a bit’ to Trump’s policies
Mnuchin, who served under Trump in the Republican’s first term in office, said does not see signs of an imminent slowdown for the U.S. economy.
Investors hope April 2 could bring some tariff clarity and relief. That may not happen
Stocks have been in turmoil, as investors struggle to price in the breadth of President Donald Trump’s policies that are shifting the lines of global […]
Shein ramps up charm offensive as London IPO nears
Shein is detailing its commitment to product safety after it clashed with U.K. lawmakers on its supply chain and recalled a dangerous hair dryer.